Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
Thursday, June 16th, 2005Preliminary results from a large, randomized clinical trial for patients with previously untreated recurrent or metastatic breast cancer — cancer that has spread from the breast to other parts of the body — show that those patients who received bevacizumab (Avastinâ„¢) in combination with standard chemotherapy had a longer time period before their cancer progressed […]
Loading ...